PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsneutropenia
MeSH D009503 - neutropenia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D000380:Agranulocytosis
0 Companies
0 Drugs
Success rate
D009503: 
Neutropenia
D064147:Febrile neutropenia
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaAmphotericin b Amphotericin B  1995-03-31   
Ciprofloxacin Ciprofloxacin  2004-06-09   
Lipegfilgrastim Lonquex  2013-07-25   
Filgrastim Tevagrastim  2008-09-15   
Vancomycin Vancomycin  2015-12-23   
Taro PharmaceuticalCiprofloxacin Ciprofloxacin  2004-10-06   
NATCO PharmaCiprofloxacin Ciprofloxacin  2004-06-09   
MylanItraconazole Itraconazole  2012-07-20   
Vancomycin Vancomycin  2008-12-30   
Mayne GroupItraconazole Tolsura 2023-07-25 2018-12-11   
Johnson & JohnsonItraconazole Sporanox  1992-09-11   
GSKCeftazidime Ceptaz  1990-09-27   
Ceftazidime Pentacef  1995-11-07   
Lupin ResearchVancomycin Vancomycin  2015-01-28   
SandozItraconazole Itraconazole  2004-05-28   
Meropenem Meropenem  2011-03-29   
Vancomycin Vancomycin  2010-04-27   
Filgrastim Zarxio  2015-03-06   
Filgrastim Zarzio  2009-02-06   
Pegfilgrastim Ziextenzo  2019-11-04   
Ciprofloxacin Ciloxan  1990-12-31   
Hydrocortisone, Ciprofloxacin Cipro  1998-02-10   
Dexamethasone, Ciprofloxacin Ciprodex 2025-06-04 2003-07-18   
AbbVieAvibactam, Ceftazidime Avycaz 2026-01-07 2015-02-25   
1
2
3
4
5
6
...
10
>
Clinical Trials
Historical Success Rate
Phase 1
67%
26/39
Phase 2
48%
27/56
Phase 3
48%
26/54
Approved: 15Overall Success rate: 15%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Mayne Group
1
2
3
4
5
6
7
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use